Geng Meiyu (front row, left) and her research team at the Chinese Academy of Sciences have successfully developed the first world’s medication for Alzheimer’s Disease in nearly 20 years. Photo: Xinhua

China approves Oligomannate, world’s first new Alzheimer’s drug in 20 years and it is based on seaweed

  • Clinical trial shows effectiveness in treating mild to moderate forms of the disease, and it may even improve cognitive function
  • Researchers noticed elderly people who regularly eat seaweed are less likely to develop the condition
Topic |   China science

TOP PICKS

Geng Meiyu (front row, left) and her research team at the Chinese Academy of Sciences have successfully developed the first world’s medication for Alzheimer’s Disease in nearly 20 years. Photo: Xinhua
READ FULL ARTICLE